Pierre-Emmanuel Schwab1, Patricia Lavand'homme2, Jean Cyr Yombi3, Emmanuel Thienpont4. 1. Department of Orthopaedic Surgery, Cliniques Universitaires Saint Luc, Av. Hippocrate 10, 1200, Brussels, Belgium. 2. Department of Anesthesia and Perioperative Medicine, Cliniques Universitaires Saint Luc, Av. Hippocrate 10, 1200, Brussels, Belgium. 3. Department of Internal and Perioperative Medicine, Cliniques Universitaires Saint Luc, Av. Hippocrate 10, 1200, Brussels, Belgium. 4. Department of Orthopaedic Surgery, Cliniques Universitaires Saint Luc, Av. Hippocrate 10, 1200, Brussels, Belgium. emmanuel.thienpont@uclouvain.be.
Abstract
PURPOSE: It is intuitive that blood loss is lower after unicompartmental knee arthroplasty (UKA), but the difference in potential blood loss between UKA and total knee arthroplasty (TKA) has not yet been studied extensively. The hypothesis of this study was that blood loss is less important in UKA and that it can be performed without transfusion risk, even in preoperative anaemic patients. METHODS: A comparative matched retrospective study on 105 (57F/48M) UKA patients with a mean (SD) age of 64 (10) years, a mean (SD) BMI of 29.5 (5) kg/m(2) and a mean (SD) preoperative haemoglobin (Hb) level of 13.7 (1.5) g/dl was matched with 105 TKA patients for age, BMI, gender, ASA score and preoperative alignment. Blood loss was measured peroperatively and as a substitute for blood loss by mean Hb and haematocrit drop at day 2 and 4 postoperatively. RESULTS: Mean (SD) visible blood loss was lower for UKA [20 (10) cc vs. 110 (10) cc; P < 0.0001]. Mean (SD) Hb levels were higher for UKA compared to TKA at day 2 [12.9 (1.4) vs. 12.1 (1.4) g/dl; P < 0.0001], day 4 [12.7 (1.4) vs. 11.5 (1.6) g/dl; P < 0.0001] and day 21 [13.2 (1.4) vs. 12.7 (1.3) g/dl; P = 0.0185]. Hidden blood loss was more important for TKA (0.2 vs. 0.6 g/dl). Transfusion rates were 0 % for UKA and 2 % for TKA. Transfused patients were all female with moderate preoperative anaemia (Hb < 11 g/dl) undergoing TKA. CONCLUSIONS: Haemoglobin drop is higher with more hidden blood loss in TKA. Patients with preoperative anaemia can undergo UKA without a risk for transfusion; however, women with moderate anaemia planned for TKA are at risk. The transfusion rate for TKA is, however, very low, and so, expected survival of the implant versus risk of co-morbidity should be discussed with the patient. LEVEL OF EVIDENCE: Therapeutic study, Level III.
PURPOSE: It is intuitive that blood loss is lower after unicompartmental knee arthroplasty (UKA), but the difference in potential blood loss between UKA and total knee arthroplasty (TKA) has not yet been studied extensively. The hypothesis of this study was that blood loss is less important in UKA and that it can be performed without transfusion risk, even in preoperative anaemic patients. METHODS: A comparative matched retrospective study on 105 (57F/48M) UKA patients with a mean (SD) age of 64 (10) years, a mean (SD) BMI of 29.5 (5) kg/m(2) and a mean (SD) preoperative haemoglobin (Hb) level of 13.7 (1.5) g/dl was matched with 105 TKA patients for age, BMI, gender, ASA score and preoperative alignment. Blood loss was measured peroperatively and as a substitute for blood loss by mean Hb and haematocrit drop at day 2 and 4 postoperatively. RESULTS: Mean (SD) visible blood loss was lower for UKA [20 (10) cc vs. 110 (10) cc; P < 0.0001]. Mean (SD) Hb levels were higher for UKA compared to TKA at day 2 [12.9 (1.4) vs. 12.1 (1.4) g/dl; P < 0.0001], day 4 [12.7 (1.4) vs. 11.5 (1.6) g/dl; P < 0.0001] and day 21 [13.2 (1.4) vs. 12.7 (1.3) g/dl; P = 0.0185]. Hidden blood loss was more important for TKA (0.2 vs. 0.6 g/dl). Transfusion rates were 0 % for UKA and 2 % for TKA. Transfused patients were all female with moderate preoperative anaemia (Hb < 11 g/dl) undergoing TKA. CONCLUSIONS: Haemoglobin drop is higher with more hidden blood loss in TKA. Patients with preoperative anaemia can undergo UKA without a risk for transfusion; however, women with moderate anaemia planned for TKA are at risk. The transfusion rate for TKA is, however, very low, and so, expected survival of the implant versus risk of co-morbidity should be discussed with the patient. LEVEL OF EVIDENCE: Therapeutic study, Level III.
Entities:
Keywords:
Blood loss; Total knee arthroplasty; Transfusion; Unicompartmental knee arthroplasty
Authors: Matthew R Bong; Vipul Patel; Eric Chang; Paul S Issack; Rudi Hebert; Paul E Di Cesare Journal: J Arthroplasty Date: 2004-04 Impact factor: 4.757
Authors: Jai Hyung Park; Mohammad R Rasouli; S M Javad Mortazavi; Anthony T Tokarski; Mitchell G Maltenfort; Javad Parvizi Journal: J Bone Joint Surg Am Date: 2013-10-02 Impact factor: 5.284
Authors: David J Beard; Loretta J Davies; Jonathan A Cook; Graeme MacLennan; Andrew Price; Seamus Kent; Jemma Hudson; Andrew Carr; Jose Leal; Helen Campbell; Ray Fitzpatrick; Nigel Arden; David Murray; Marion K Campbell Journal: Health Technol Assess Date: 2020-04 Impact factor: 4.014
Authors: Andrew D Pearle; Jelle P van der List; Lily Lee; Thomas M Coon; Todd A Borus; Martin W Roche Journal: Knee Date: 2017-02-06 Impact factor: 2.199
Authors: Sevgi Atar; Esma Demirhan; Haluk Cabuk; Kaya Turan; Süleyman Semih Dedeoglu; Ömer Kuru Journal: Indian J Orthop Date: 2021-10-26 Impact factor: 1.251